JCIA
VRTX icon

Jackson Creek Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Jackson Creek Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,065
Closed -$278K – 382
2022
Q1 		$278K Buy
+1,065
New +$253K 0.1% 286
2021
Q1 		– Sell
-2,947
Closed -$696K – 376
2020
Q4 		$696K Sell
2,947
-664
-18% -$152K 0.27% 200
2020
Q3 		$983K Buy
+3,611
New +$996K 0.45% 49

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jackson Creek Investment Advisors's VRTX Position: Q2 2022 in Review

Jackson Creek Investment Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q2 2022, closing a stake of 1,065 shares — an estimated $278K sold.

Jackson Creek Investment Advisors first reported a position in VRTX in Q3 2020 and held it in 3 quarters. The position peaked at $983K in Q3 2020. 1,106 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.

  • Jackson Creek Investment Advisors reported no remaining Vertex Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 1,065 Vertex Pharmaceuticals shares in Q2 2022, an estimated $278K.
  • Jackson Creek Investment Advisors first reported a position in Vertex Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Jackson Creek Investment Advisors's Vertex Pharmaceuticals position peaked at $983K in Q3 2020.
  • 1,106 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.